Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline

Abstract

BackgroundDiabetes-associated cognition decline is one of central nervous system complications in diabetic mellitus, while its pathogenic mechanism remains unclear. In this study, 1H nuclear magnetic resonance-based metabonomics and immunohistochemistry was used to explore key metabolic alterations in hippocampus of type 2 diabetic db/db mice with cognition decline in order to advance understanding of mechanisms underlying the pathogenesis of the disease.ResultsMetabonomics reveals that lactate level was significantly increased in hippocampus of db/db mice with cognition decline compared with age-matched wild-type mice. Several tricarboxylic acid cycle intermediates including succinate and citrate were reduced in hippocampus of db/db mice with cognition decline. Moreover, an increase in glutamine level and a decrease in glutamate and γ-aminobutyric acid levels were observed in db/db mice. Results from immunohistochemistry analysis show that glutamine synthetase was increased and glutaminase and glutamate decarboxylase were decreased in db/db mice.ConclusionsOur results suggest that the development of diabetes-associated cognition decline in db/db mice is most likely implicated in a reduction in energy metabolism and a disturbance of glutamate-glutamine shuttling between neurons and astrocytes in hippocampus.Electronic supplementary materialThe online version of this article (doi:10.1186/s13041-016-0223-5) contains supplementary material, which is available to authorized users.

Metabolic and transcriptional changes in seminal plasma of asthenozoospermia patients

“…Then, Pyr is oxidized to acetyl‐co‐enzyme A (CoA) under an aerobic condition, ultimately generating CO 2 , H 2 O, and ATP through the TCA cycle. Meanwhile, Pyr can be transformed into Lac and Ala via the anaerobic glycolysis pathway and transamination, respectively (Zheng et al, ). In the present study, a notable decrease in the Pyr level might indicate that less acetyl‐CoA was produced and it entered into the TCA cycle in AS patients, which was further verified by reduction in three TCA intermediates (Suc, Mal, and Cit).…”

Metabolomic Analysis Identifies Lactate as an Important Pathogenic Factor in Diabetes-associated Cognitive Decline Rats

“…In a subsequent study, they further identified CMPF as a link between ␤ cell dysfunction and diabetes that could be targeted therapeutically (17,18). By nuclear magnetic resonance (NMR)-based metabolomics, we have previously shown that the development of DACD is related to alterations in glucose metabolism and to the impaired glutamate-glutamine cycle in the hippocampus of the diabetic dyslipidemia mouse model (db/db mice) (19). Furthermore, by employing 13 C NMR with labeled glucose and acetate as substrates, we observed an altered rate of particular metabolic pathways (i.e.…”

Metabolomics Study on Improvement of Mild Cognitive Impairment by SCPE: a UPLC-Q/TOF-MS Mass Spectrometric Study

“…In order to clarify the action mechanism of the 40 biomarkers obtained in the previous step, this part analyzed their pathways, mainly based on KEGG and HMDB database to annotate metabolite metabolic pathways. Using MetaboAnalyst [6] online software analysis tool, the pathway analysis, metabolite input format of the differential metabolites identified in the previous step is Compoundname/HMDBID/KEGG ID, and the Impact value is set to greater than 0.1 as the screening criteria for potential main metabolic pathways. After analysis, four main metabolic pathways were obtained, which were as follows: Phenylalanine metabolism; Alanine, aspartate and glutamate metabolism; Valine, leucine and isoleucine biosynthesis; D-Glutamine and D-glutamate metabolism.…”

“…Metabolomics is another part of systems biology after genomics and proteomics. It mainly makes quantitative analysis of all metabolites in local tissues and body fluids of organisms, and looks for the relationship between metabolites and physiological and pathological changes in vivo [6]. The research objects of metabolomics are mostly small molecular substances with relative molecular weight less than 1000 Da.…”